P724: UPDATED SUBSTUDY RESULTS FOR IVOSIDENIB IN IDH1-MUTANT RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROME

• Courtney Dinardo,
• Gail Roboz,
• Justin M. Watts,
• Yazan Madanat,
• Gabrielle T Prince,
• Praneeth Baratam,
• Stéphane de Botton,
• Anthony Stein,
• James M Foran,
• Martha L Arellano,
• David Sallman,
• Dylan M Marchione,
• Xiaofei Bai,
• Prapti A Patel,
• Stephanie M Kapsalis,
• Guillermo Garcia-Manero,
• Amir Fathi

Affiliations

Courtney Dinardo

1 University of Texas MD Anderson Cancer Center, Houston, United States

Gail Roboz

2 Weill Cornell Medicine and The New York Presbyterian Hospital,, New York, United States

Justin M. Watts

3 University of Miami, Sylvester Comprehensive Cancer Center, Miami, United States

Yazan Madanat

4 University of Texas Southwestern Medical Center, Dallas, United States

Gabrielle T Prince

5 Johns Hopkins Hospital, Baltimore, United States

Praneeth Baratam

6 Medical University of South Carolina, Charleston, United States

Stéphane de Botton

7 Institut Gustave Roussy, Villejuif, France

Anthony Stein

8 City of Hope, Duarte, United States

James M Foran

9 Mayo Clinic, Jacksonville, United States

Martha L Arellano

10 Winship Cancer Institute, Emory University School of Medicine, Atlanta, United States

David Sallman

11 Moffitt Cancer Center, Tampa, United States

Dylan M Marchione

12 Servier Pharmaceuticals, LLC, Boston, United States

Xiaofei Bai

12 Servier Pharmaceuticals, LLC, Boston, United States

Prapti A Patel

12 Servier Pharmaceuticals, LLC, Boston, United States

Stephanie M Kapsalis

12 Servier Pharmaceuticals, LLC, Boston, United States

Guillermo Garcia-Manero

1 University of Texas MD Anderson Cancer Center, Houston, United States

Amir Fathi

13 Massachusetts General Hospital Cancer Center, Boston, United States